Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-25T17:45:26.315Z Has data issue: false hasContentIssue false

Onset of improvement under fluoxetine and moclobemide

Published online by Cambridge University Press:  16 April 2020

HH Stassen
Affiliation:
Psychiatric University Hospital Zurich, Research Department, PO Box 68, CH-8029 Zurich, Switzerland
J Angst
Affiliation:
Psychiatric University Hospital Zurich, Research Department, PO Box 68, CH-8029 Zurich, Switzerland
A Delini-Stula
Affiliation:
Psychiatric University Hospital Zurich, Research Department, PO Box 68, CH-8029 Zurich, Switzerland
Get access

Summary

In a meta-analysis of the selective serotonin reuptake inhibitor fluoxetine (n = 440) and the reversible and selective monoamine oxidase-A inhibitor moclobemide (n = 437) we investigated the time course of improvement over 6 weeks for these two classes of anti-depressants. Two different methods of approach were applied: (1) repeated measurement analysis of variance in combination with regression analysis, and (2) a survival-analytical approach that allowed us to determine onset of improvement for the individual patient, to distinguish between early and late improvers, to assess the predictive value of early improvement, and to adequately process premature withdrawals. The two antidepressants of large biochemical and pharmacological differences yielded virtually identical response- and drop-out rates, and exhibited no difference with respect to the time course of improvement. Onset of improvement occurred in more than half of the patients within the first 2 weeks of treatment, and early improvement was highly predictive of later outcome. In particular, there was no indication for a delayed onset of action of antidepressants. We suggest that future studies should be standardised with respect to washout period and sufficiently dense assessments during the first 2 weeks of trial. Thus, patient samples can be subdivided reproducibly into early-, late-, partial- and non-remitters. This, in turn, may help to identify “true” drug responders, and to discover why in some patients recovery becomes “stuck”. Data already held by the pharmaceutical companies should be reanalysed in this respect.

Type
Research Article
Copyright
Copyright © Elsevier, Paris 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Angst, JTime-lag of antidepressant effect In: Depressive Disorders, Symposia Medica Hoechst 13, Symposium Rome 1977 Schattauer Stuttgart 1978 468Google Scholar
Grey, PFluoxetine and onset of its therapeutic effect Am J Psychiatry 1993; 150: 1984Google ScholarPubMed
Khan, A, Cohen, S, Dager, S, Avery, DH, Dunner, DLOnset of response in relation to outcome in depressed outpatients with placebo and imipramine J Affect Disord 1989; 17: 3338CrossRefGoogle ScholarPubMed
Lavori, PW, Dawson, R, Mueller, TICausal estimation of time-varying treatment effects in observational studies: application to depressive disorder Stat Med 1994; 13: 10891100CrossRefGoogle ScholarPubMed
Lavori, PW, Dawson, R, Mueller, TI, Warshaw, M, Swartz, A, Leon, AAnalysis of course of psychopathology: transitions among states of health and illness Int J Meth Psychiatr Res 1996; 6: 3213343.3.CO;2-I>CrossRefGoogle Scholar
Overall, JEJustifying a “fast acting” claim for antidepressant drugs Psychopharmacology Bull 1995; 31: 4555Google ScholarPubMed
Parker, GOn brightening up: triggers and trajectories to recovery from depression Br J Psychiatry 1996; 168: 263264CrossRefGoogle ScholarPubMed
Quitkin, FM, Rabkin, JD, Markowitz, JM, et al.Use of pattern analysis to identify true drug response Arch Gen Psychiatry 1987; 44: 259264CrossRefGoogle ScholarPubMed
Stassen, HH, Delini-Stula, A, Angst, JTime course of improvement under antidepressant treatment: A survival-analytical approach Eur Psychopharmacol 1993; 3: 127135Google ScholarPubMed
Stassen, HH, Angst, J, Delini-Stula, ASeverity at baseline and onset of improvement in depression. Meta-analysis of imipramine and moclobemide versus placebo Eur J Psychiatry 1994; 9: 129136CrossRefGoogle Scholar
Stassen, HH, Angst, J, Delini-Stula, ADelayed onset of action of antidepressant drugs? Survey of results of Zurich metaanalyses Pharmacopsychiatry 1996; 29: 8796CrossRefGoogle Scholar
Tollefson, GD, Holman, SLHow long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo Int Clin Psychopharmacology 9 1994 245250CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.